Anybody can develop a deep vein thrombosis (DVT). It's a serious public health issue. But some are more likely to get this clot – or even die from it – than others due to differences in treatment.
The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification ...
The American Heart Association and the American College of Cardiology released unified national guidelines for diagnosing and ...
Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...
A new clinical classification system is presented to define the severity of an acute pulmonary embolism (PE) and assist in developing adult treatment strategies in a clinical practice guideline issued ...
Hosted on MSN
Symptoms of blood clot in the arm and DVT treatment
A blood clot in the arm can lead to symptoms of pain, swelling, and skin discoloration, sometimes with visibly bulging veins and shoulder or neck discomfort. The clot, called a deep vein thrombosis ...
Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...
Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of ...
The first clinical practice guideline on acute pulmonary embolism (PE) from the American Heart Association and the American ...
The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A clot-removal device successfully removed chronic ...
The first clinical use of heparin was for chemoprophylaxis in surgical patients. In 1937, Murray and Crafoord published data evaluating surgical patients who received prophylaxis for DVT. 14 Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results